CLDN1 and melanoma: Claudin-1 expression in the membrane, cytoplasm, and nucleus is altered in human malignancies including colon cancer [6], nasopharynx carcinoma [7], thyroid carcinoma [8], breast cancer [9], and melanoma [10, 11].